Individualized Neurodevelopmental Treatment
1 other identifier
interventional
1
1 country
1
Brief Summary
The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 2008
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 1, 2009
CompletedFirst Posted
Study publicly available on registry
June 17, 2009
CompletedJune 17, 2009
June 1, 2009
3 months
June 1, 2009
June 16, 2009
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- spastic tetraplegia
You may not qualify if:
- vision problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hellenic Society for Disabled Children
Thessaloniki, THessaloniki, 25155, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 1, 2009
First Posted
June 17, 2009
Study Start
January 1, 2008
Primary Completion
April 1, 2008
Study Completion
April 1, 2008
Last Updated
June 17, 2009
Record last verified: 2009-06